Standout Papers
- Laparoscopy Compared With Laparotomy for Comprehensive Surgical Staging of Uterine Cancer: Gynecologic Oncology Group Study LAP2 (2009)
- Recurrence and Survival After Random Assignment to Laparoscopy Versus Laparotomy for Comprehensive Surgical Staging of Uterine Cancer: Gynecologic Oncology Group LAP2 Study (2012)
- Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study (2020)
Immediate Impact
3 from Science/Nature 53 standout
Citing Papers
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
2024 Standout
A gut microbial signature for combination immune checkpoint blockade across cancer types
2024 Standout
Works of Sudarshan Sharma being referenced
Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study
2020 Standout
Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or -refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinoma
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Sudarshan Sharma | 1371 | 948 | 453 | 40 | 2.0k | |
| Stewart F. Cramer | 1001 | 775 | 346 | 74 | 2.1k | |
| Robin Crawford | 727 | 730 | 462 | 61 | 1.9k | |
| Mark Adelson | 587 | 1148 | 830 | 44 | 1.8k | |
| Pamela J. Paley | 877 | 1255 | 519 | 40 | 2.2k | |
| Alexander W. Miller | 663 | 898 | 577 | 33 | 1.7k | |
| Cristina Bonazzi | 708 | 1348 | 554 | 46 | 2.0k | |
| Harrison Ball | 975 | 1542 | 1113 | 46 | 2.4k | |
| Lynn Hirschowitz | 609 | 656 | 490 | 73 | 1.6k | |
| Tim H. Parmley | 558 | 569 | 269 | 74 | 1.8k | |
| Takashi Onda | 1145 | 1344 | 786 | 75 | 2.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...